- 現金殖利率: N/A、總殖利率: 0、5年平均現金配發率: N/A
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | -0.18 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2022 (9) | 0.07 | -61.11 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2021 (8) | 0.18 | 500.0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2020 (7) | 0.03 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2019 (6) | -0.57 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2018 (5) | -0.45 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2017 (4) | -0.81 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2016 (3) | -1.52 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 23Q4 (20) | -0.02 | 71.43 | 0.0 | -0.07 | 69.57 | -333.33 | -0.18 | -12.5 | -357.14 |
| 23Q3 (19) | -0.07 | 0 | -187.5 | -0.23 | -155.56 | -283.33 | -0.16 | -77.78 | -277.78 |
| 23Q2 (18) | 0.00 | 100.0 | -100.0 | -0.09 | -800.0 | -800.0 | -0.09 | 10.0 | -550.0 |
| 23Q1 (17) | -0.10 | -400.0 | -100.0 | -0.01 | -133.33 | 83.33 | -0.10 | -242.86 | -100.0 |
| 22Q4 (16) | -0.02 | -125.0 | 75.0 | 0.03 | 150.0 | 175.0 | 0.07 | -22.22 | -61.11 |
| 22Q3 (15) | 0.08 | 33.33 | -55.56 | -0.06 | -500.0 | -133.33 | 0.09 | 350.0 | -66.67 |
| 22Q2 (14) | 0.06 | 220.0 | -25.0 | -0.01 | 83.33 | -108.33 | 0.02 | 140.0 | -80.0 |
| 22Q1 (13) | -0.05 | 37.5 | -600.0 | -0.06 | -50.0 | -220.0 | -0.05 | -127.78 | -600.0 |
| 21Q4 (12) | -0.08 | -144.44 | -366.67 | -0.04 | -122.22 | -233.33 | 0.18 | -33.33 | 500.0 |
| 21Q3 (11) | 0.18 | 125.0 | 263.64 | 0.18 | 50.0 | 300.0 | 0.27 | 170.0 | 0 |
| 21Q2 (10) | 0.08 | 700.0 | 300.0 | 0.12 | 140.0 | 400.0 | 0.10 | 900.0 | -9.09 |
| 21Q1 (9) | 0.01 | -66.67 | -93.33 | 0.05 | 66.67 | 127.78 | 0.01 | -66.67 | -93.33 |
| 20Q4 (8) | 0.03 | 127.27 | 107.69 | 0.03 | 133.33 | 160.0 | 0.03 | 0 | 105.26 |
| 20Q3 (7) | -0.11 | -175.0 | 45.0 | -0.09 | -125.0 | 50.0 | 0.00 | -100.0 | 100.0 |
| 20Q2 (6) | -0.04 | -126.67 | -500.0 | -0.04 | 77.78 | 50.0 | 0.11 | -26.67 | 450.0 |
| 20Q1 (5) | 0.15 | 138.46 | 0 | -0.18 | -260.0 | -1700.0 | 0.15 | 126.32 | 0 |
| 19Q4 (4) | -0.39 | -95.0 | 0.0 | -0.05 | 72.22 | 0.0 | -0.57 | -216.67 | 0.0 |
| 19Q3 (3) | -0.20 | -2100.0 | 0.0 | -0.18 | -125.0 | 0.0 | -0.18 | -1000.0 | 0.0 |
| 19Q2 (2) | 0.01 | 0 | 0.0 | -0.08 | -700.0 | 0.0 | 0.02 | 0 | 0.0 |
| 19Q1 (1) | 0.00 | 0.0 | 0.0 | -0.01 | 0.0 | 0.0 | 0.00 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/3 | 0.73 | -18.43 | -12.13 | 2.85 | 11.78 | 2.82 | N/A | - | ||
| 2024/2 | 0.9 | -24.1 | 5.29 | 2.09 | 22.4 | 2.96 | N/A | - | ||
| 2024/1 | 1.19 | 35.9 | 39.02 | 1.19 | 39.02 | 2.81 | N/A | - | ||
| 2023/12 | 0.87 | 17.07 | -13.34 | 9.8 | -10.08 | 2.39 | 2.47 | - | ||
| 2023/11 | 0.75 | -3.58 | -21.89 | 8.92 | -9.78 | 2.45 | 2.41 | - | ||
| 2023/10 | 0.77 | -16.75 | -16.77 | 8.16 | -8.51 | 2.45 | 2.41 | - | ||
| 2023/9 | 0.93 | 24.27 | -0.31 | 7.4 | -7.42 | 2.33 | 2.54 | - | ||
| 2023/8 | 0.75 | 14.72 | -29.15 | 6.53 | -7.37 | 2.32 | 2.55 | - | ||
| 2023/7 | 0.65 | -28.83 | -26.84 | 5.72 | -4.5 | 2.45 | 2.42 | - | ||
| 2023/6 | 0.92 | 4.35 | -0.75 | 5.06 | -0.63 | 2.52 | 2.21 | - | ||
| 2023/5 | 0.88 | 21.39 | 3.79 | 4.15 | -0.69 | 2.44 | 2.29 | - | ||
| 2023/4 | 0.72 | -13.53 | -19.97 | 3.27 | -1.68 | 2.41 | 2.31 | - | ||
| 2023/3 | 0.84 | -2.24 | -17.9 | 2.55 | 4.98 | 2.55 | 2.15 | - | ||
| 2023/2 | 0.86 | 0.19 | 22.15 | 1.71 | 21.24 | 2.72 | 2.02 | - | ||
| 2023/1 | 0.85 | -15.28 | 20.26 | 0.85 | 20.26 | 2.82 | 1.95 | - | ||
| 2022/12 | 1.01 | 5.51 | 23.97 | 10.89 | -7.92 | 2.89 | 1.92 | - | ||
| 2022/11 | 0.96 | 2.73 | 13.81 | 9.89 | -10.24 | 2.82 | 1.97 | - | ||
| 2022/10 | 0.93 | -0.28 | -10.48 | 8.92 | -12.31 | 2.92 | 1.9 | - | ||
| 2022/9 | 0.93 | -11.67 | -32.28 | 7.98 | -12.75 | 2.88 | 1.98 | - | ||
| 2022/8 | 1.06 | 18.46 | 11.15 | 7.05 | -9.46 | 2.87 | 1.98 | - | ||
| 2022/7 | 0.89 | -3.45 | 11.33 | 5.99 | -12.35 | 2.66 | 2.14 | - | ||
| 2022/6 | 0.92 | 9.14 | -0.31 | 5.1 | -15.47 | 2.67 | 2.13 | - | ||
| 2022/5 | 0.85 | -6.4 | -14.05 | 4.18 | -18.22 | 2.77 | 2.06 | - | ||
| 2022/4 | 0.9 | -11.3 | -22.98 | 3.33 | -19.38 | 2.62 | 2.17 | - | ||
| 2022/3 | 1.02 | 45.45 | -13.28 | 2.43 | -17.87 | 2.43 | 2.21 | - | ||
| 2022/2 | 0.7 | -1.34 | -9.63 | 1.41 | -20.64 | 2.22 | 2.41 | - | ||
| 2022/1 | 0.71 | -12.66 | -29.07 | 0.71 | -29.07 | 2.36 | 2.27 | - | ||
| 2021/12 | 0.81 | -3.13 | -20.23 | 11.82 | 30.15 | 2.69 | 1.74 | - | ||
| 2021/11 | 0.84 | -19.2 | -12.11 | 11.01 | 36.78 | 3.25 | 1.44 | - | ||
| 2021/10 | 1.04 | -24.56 | 3.86 | 10.18 | 43.44 | 3.37 | 1.39 | - | ||
| 2021/9 | 1.38 | 44.98 | 149.33 | 9.16 | 49.89 | 3.13 | 1.3 | 因美國疫情影響降低,醫療器材及遙控模型市場需求強勁,包括電信大廠合作案已出貨 | ||
| 2021/8 | 0.95 | 18.65 | 77.82 | 7.78 | 40.58 | 2.68 | 1.52 | 因美國疫情影響降低，醫療器材及遙控模型市場需求強勁 | ||
| 2021/7 | 0.8 | -13.56 | 14.75 | 6.83 | 36.52 | 2.71 | 1.5 | - | ||
| 2021/6 | 0.93 | -5.89 | 4.74 | 6.03 | 39.26 | 3.08 | 1.17 | - | ||
| 2021/5 | 0.98 | -16.12 | 58.29 | 5.11 | 49.21 | 3.33 | 1.09 | 因美國疫情影響降低,醫療器材及遙控模型市場需求強勁 | ||
| 2021/4 | 1.17 | -0.14 | 85.86 | 4.13 | 47.3 | 3.12 | 1.16 | 因美國疫情影響降低,醫療器材及遙控模型市場需求強勁 | ||
| 2021/3 | 1.17 | 51.58 | 70.46 | 2.95 | 36.05 | 2.95 | 1.25 | 因美國疫情影響降低,醫療器材及遙控模型市場需求強勁 | ||
| 2021/2 | 0.78 | -22.57 | 6.19 | 1.78 | 19.98 | 2.8 | 1.32 | - | ||
| 2021/1 | 1.0 | -1.77 | 33.41 | 1.0 | 33.41 | 2.98 | 1.24 | - | ||
| 2020/12 | 1.02 | 6.72 | 69.24 | 9.07 | 11.27 | 2.97 | 1.22 | 美國醫療器材通路客戶受疫情影響降低,營業額回升,美國遙控模型子公司感恩節與耶誕節旺季拉貨及通路商強勁需求所致 | ||
| 2020/11 | 0.95 | -4.51 | 54.2 | 8.05 | 6.32 | 2.51 | 1.44 | 美國醫療器材通路客戶受疫情影響降低,營業額回升,美國遙控模型子公司感恩節與耶誕節旺季拉貨及通路商強勁需求所致 | ||
| 2020/10 | 1.0 | 81.09 | 32.32 | 7.09 | 2.01 | 2.09 | 1.74 | - | ||
| 2020/9 | 0.55 | 3.4 | -23.48 | 6.09 | -1.81 | 1.78 | 2.12 | - | ||
| 2020/8 | 0.53 | -23.42 | 20.62 | 5.54 | 1.07 | 2.12 | 1.79 | - | ||
| 2020/7 | 0.7 | -21.09 | -3.73 | 5.0 | -0.52 | 2.2 | 1.72 | - | ||
| 2020/6 | 0.88 | 42.21 | 4.26 | 4.31 | 1.05 | 2.14 | 1.46 | - | ||
| 2020/5 | 0.62 | -1.52 | -17.31 | 3.42 | -1.06 | 1.94 | 1.61 | - | ||
| 2020/4 | 0.63 | -8.42 | 0.66 | 2.8 | 3.4 | 2.05 | 1.53 | - | ||
| 2020/3 | 0.69 | -5.55 | -13.88 | 2.17 | 4.21 | 2.17 | 1.42 | - | ||
| 2020/2 | 0.73 | -2.73 | 27.25 | 1.48 | 15.49 | 2.08 | 1.48 | - | ||
| 2020/1 | 0.75 | 24.59 | 5.93 | 0.75 | 5.93 | 1.97 | 1.57 | - | ||
| 2019/12 | 0.6 | -2.75 | 7.05 | 8.17 | -6.26 | 1.98 | 1.64 | - | ||
| 2019/11 | 0.62 | -18.06 | -6.28 | 7.57 | -7.12 | 2.1 | 1.55 | - | ||
| 2019/10 | 0.76 | 4.72 | 0.64 | 6.95 | -7.19 | 1.92 | 1.69 | - | ||
| 2019/9 | 0.72 | 62.99 | 19.93 | 6.2 | -7.89 | 1.89 | 2.0 | - | ||
| 2019/8 | 0.44 | -38.89 | -33.02 | 5.48 | -10.57 | 2.02 | 1.87 | - | ||
| 2019/7 | 0.72 | -14.53 | 17.61 | 5.03 | -8.14 | 2.32 | 1.62 | - | ||
| 2019/6 | 0.85 | 12.78 | 9.72 | 4.29 | -11.56 | 2.23 | 1.74 | - | ||
| 2019/5 | 0.75 | 19.87 | -25.12 | 3.46 | -15.13 | 0.0 | N/A | - | ||
| 2019/4 | 0.63 | -21.65 | -20.33 | 2.71 | -11.92 | 0.0 | N/A | - |
